VINB/INDO/TV-AE actions on serum lipid metabolism disruptions in healthy and treated ratsa.
| Group | Dose | Triacylglycerol (mg dL−1) | Total cholesterol (mg dL−1) | HDL-cholesterol (mg dL−1) |
|---|---|---|---|---|
| CONT (NaCl) | (5 mL kg−1) | 80.00 ± 5.28 | 61.34 ± 4.51 | 32.13 ± 2.45 |
| VINB | (2 mg kg−1) | 78.40 ± 6.81 | 62.03 ± 5.12 | 30.40 ± 2.30 |
| VINB/TV-AE | (100 mg kg−1) | 77.37 ± 4.02 | 61.45 ± 3.59 | 33.12 ± 0.93 |
| (200 mg kg−1) | 79.80 ± 2.87 | 60.23 ± 5.10 | 26.06 ± 1.21*# | |
| INDO | (30 mg kg−1) | 67.12 ± 3.50* | 78.22 ± 2.15* | 35.46 ± 1.57 |
| INDO/TV-AE | (100 mg kg−1) | 70.59 ± 4.21* | 75.68 ± 3.17* | 40.16 ± 3.55*# |
| (200 mg kg−1) | 81.35 ± 5.32# | 63.27 ± 4.22# | 44.86 ± 2.22*# |
VINB/INDO/TV-AE effects were reflected by serum lipid metabolism assessed in healthy rats and rats treated with VINB (2 mg kg−1) or INDO (30 mg kg−1). Results are expressed as mean ± SEM; n = 7 in each group. Data was analyzed by Statview ANOVA. Data are expressed as mean ± standard error (n = 7); *P < 0.05 versus control group, #P < 0.05 versus VINB/INDO-groups.